Profile
VVOS ABT BSX-PA BSX SYK MDT
Company Name Vivos Therapeutics, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $22.56M $233.90B $175.45B $154.34B $150.40B $113.25B
Employees 0.11K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO R. Kirk Huntsman Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
VVOS ABT BSX-PA BSX SYK MDT
Quant Rating Score 1 4 3 3 3
Quant Rating Strong Sell Buy Neutral Neutral Neutral
Trading
VVOS ABT BSX-PA BSX SYK MDT
Last Close $4.21 $134.44 $122.18 $104.32 $395.28 $88.39
High 52 $5.95 $140.22 $122.18 $107.41 $399.9 $94.5
Low 52 $2.04 $100.07 $122.18 $72.96 $315.94 $76.84
Price vs. 52 Week High -29.24 % -4.12 % 0 % -2.88 % -1.16 % -6.47 %
Price vs. 52 Week Low 106.37 % 34.35 % 0 % 42.98 % 25.11 % 15.03 %
Total Return
VVOS ABT BSX-PA BSX SYK MDT
1 Month Return 79.53 % 1.11 % 0 % 1.85 % 3.32 % 3.26 %
3 Month Return 65.1 % 8.04 % 0 % 16.3 % 14.27 % 6.65 %
6 Month Return -3.66 % 18.11 % 0 % 15.03 % 9.34 % 9.19 %
9 Month Return 67.73 % 19.35 % 0 % 23.4 % 12.54 % 0.15 %
YTD Return -1.86 % 18.86 % 0 % 16.79 % 9.78 % 10.65 %
1 Year Return 75.05 % 31.23 % 0 % 37.05 % 19.05 % 14.14 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VVOS ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.7 % - - 0.83 % 3.18 %
Dividend Paid and Capex Coverage Ration (TTM) -997.93 % 1.57 % 3.96 % 3.96 % 2.2 % 1.29 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.81 %
Payout Ratio (TTM) - 28.92 % 1.13 % 1.13 % 43.2 % 76.97 %
Growth
VVOS ABT BSX-PA BSX SYK MDT
Asset Growth 42.44 % 11.2 % 12.12 % 1.89 %
Gross Profit Growth 9.04 % 5.01 % 16.12 % 3.88 %
Revenue Growth 8.91 % 4.59 % 17.61 % 3.62 %
Revenue 3 Year -84.94 % -0.18 % 36.16 % 10.52 %
Revenue 5 Year -86.95 % 34.24 % 47.52 % 20.96 %
Revenue 10 Year -63.53 % 80.43 % 104.22 % 41.05 %
EBIT Growth 35.41 % 3.71 % 14.98 % -100 %
Net Income Growth 18.02 % 134.18 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share 90.72 % 94.27 % 72.14 % -3.39 %
Net Income 5 Yeari Growth Per Share 89.89 % 271.11 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share 88 % 410.99 % 524.92 % 48.51 %
Operating Income Growth 35.41 % 5.36 % 11.1 % 15.77 %
Operating Cash Flow Growth (CFG) -6.24 % 17.86 % 37.24 % 3.79 %
Operating 3 Year CFG 86.35 % -16.72 % 77.55 % 0.13 %
Operating 5 Year CFG 76.5 % 42.4 % 76.92 % 1.55 %
Operating 10 Year CFG 78.02 % 102.79 % 143.61 % 22.45 %
EPS Growth 84.92 % 134.55 % 16.67 % 31.05 %
EPS Diluted Growth 84.92 % 133.64 % 16.82 % 30.8 %
Book Value Per Share 370.1 % 23.54 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -94.73 % 36.46 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share 126.73 % 56.53 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share -84.84 % 92.83 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - 128.74 %
Debt Growth -24.21 % -5.37 % 17.44 % 9.48 %
Free Cash Flow Growth -4 % 25.54 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
VVOS ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 58.73 % 55.89 % 67.15 % 67.15 % 63.57 % 64.06 %
Return on Assets TTM -99.6 % 16.58 % 5.06 % 5.06 % 6.21 % 5.09 %
Return on Equity TTM -170.43 % 30.76 % 9.56 % 9.56 % 10.73 % 9.62 %
Return on Capital Employed TTM -169.09 % 10.5 % 8.77 % 8.77 % 9.61 % 7.56 %
Net Income Per EBT TTM 100 % 183.58 % 81.97 % 81.97 % 85.78 % 82.85 %
EBT Per Ebit TTM 100.98 % 102.35 % 80.59 % 80.59 % 91.04 % 94.51 %
EBIT Per Revenue TTM -76.07 % 16.97 % 17.52 % 17.52 % 15.77 % 17.76 %
Cash Flow To Debt Ratio TTM -998.64 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Receivables Turnover TTM 20.37 4.38 6.52 6.52 5.86 5.15
Payables Turnover TTM 5.01 4.43 5.74 5.74 - 4.74
Inventory Turnover TTM - 2.81 2.01 2.01 1.66 2.12
Fixed Asset Turnover TTM 343.46 % 387.34 % 517.94 % 517.94 % 656.62 % 490.52 %
Asset Turnover TTM 129.66 % 51.99 % 43.73 % 43.73 % 50.47 % 36.58 %
Operating Cash Flow Per Share TTM -1.63 5.12 2.58 2.58 11.23 5.49
Free Cash Flow Per Share TTM -1.63 3.81 1.94 1.94 9.37 4.04
Cash Per Share TTM 27.25 % 391.71 % 49.08 % 49.08 % 631.12 % 699.13 %
Operating Cash Flow Sales Ratio TTM -95.51 % 21.14 % 21.72 % 21.72 % 18.47 % 21 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.1 % 74.38 % 75.37 % 75.37 % 83.42 % 73.61 %
Cash Flow Coverage Ratios TTM -998.64 % 67.59 % 32.56 % 32.56 % 29.81 % 24.7 %
Price To Free Cash Flows Ratio TTM -1.61 35.14 53.36 53.72 42.05 21.84
Price To Operating Cash Flows Ratio TTM -2.36 26.25 40.16 40.43 35.03 16.09
Price Cash Flow Ratio TTM -2.36 26.25 40.16 40.43 35.03 16.09
Income Statement (TTM)
VVOS ABT BSX-PA BSX SYK MDT
Revenue $0.02B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0.01B $23.24B $11.49B $11.49B $14.44B $21.97B
Gross Profit Ratio 60% 55.41% 68.61% 68.61% 63.91% 65.51%
EBITDA $-0.01B $10.83B $3.86B $3.86B $5.72B $5.96B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -1.68 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
VVOS ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.19B $25.64B
Total Liabilities $0.01B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0.01B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $6.75B
Total Debt $0B $15.02B $11.15B $11.15B $13.6B $28.52B
Total Assets $0.02B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
VVOS ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 134.44
ADGM Adagio Medical Holdings, Inc. 1.54
AEMD Aethlon Medical, Inc. 1.22
AFIB Acutus Medical, Inc. 0.002
AHCO AdaptHealth Corp. 9.32
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 196.82
ALUR Allurion Technologies Inc. 2.51
AMIX Autonomix Medical, Inc. Common Stock 1.4178
ANIK Anika Therapeutics, Inc. 11.25
AORT Artivion, Inc. 30.72
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.2
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 10.99
AVNS Avanos Medical, Inc. 12.35
AVR Anteris Technologies Global Corp. Common Stock 3.8
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 10.93
ETFs With Exposure to VVOS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 308.03
VXF Vanguard Extended Market Index Fund 0.00009 197.5
IWC iShares Micro-Cap ETF 0.00221 133.09
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000004423 36.52
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00009 149.82
DFSU Dimensional US Sustainability Core 1 ETF 0.0000026107 39.96
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00009 149.83
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
VEMPX Vanguard Extended Market Index InstlPlus 0.00009 369.73
Unlock